Department of Orthopaedic Surgery, Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Stoneman 10, Boston, MA 02215, USA.
J Bone Joint Surg Am. 2010 Sep;92 Suppl 1 Pt 2:188-96. doi: 10.2106/JBJS.J.00167.
Limb salvage following resection of a tumor in the proximal part of the humerus poses many challenges. Reconstructive options are limited because of the loss of periarticular soft-tissue stabilizers of the glenohumeral joint in addition to the loss of bone and articular cartilage. The purpose of this study was to evaluate the functional outcome and survival of the reconstruction following use of a humeral allograft-prosthesis composite for limb salvage.
An allograft-prosthesis composite was used to reconstruct a proximal humeral defect following tumor resection in thirty-six consecutive patients at one institution over a sixteen-year period. The reconstruction was performed at the time of a primary tumor resection in thirty cases, after a failure of a reconstruction following a previous tumor resection in five patients, and following excision of a local recurrence in one patient. The mean duration of follow-up of the living patients was five years. Glenohumeral stability, function, implant survival, fracture rate, and union rate following the reconstructions were measured. Functional outcome and implant survival were analyzed on the basis of the amount of deltoid resection, whether the glenohumeral resection had been extra-articular or intra-articular, and the length of the humerus that had been resected.
One patient sustained a glenohumeral dislocation. Deltoid resection (partial or complete) resulted in a reduced postoperative range of motion in flexion and abduction but had no effect on the mean Musculoskeletal Tumor Society score. Extra-articular resections were associated with lower Musculoskeletal Tumor Society scores. All patients had either mild or no pain and normal hand function at the time of final follow-up. The overall estimated rate of survival of the construct, with revision as the end point, was 88% at ten years. There were three failures due to progressive prosthetic loosening that necessitated removal of the construct. Four patients required an additional bone-grafting procedure to treat a delayed union of the osteosynthesis site.
An allograft-prosthesis composite used for limb salvage following tumor resection in the proximal part of the humerus is a durable construct associated with an acceptable complication rate. Deltoid preservation and intra-articular resection are associated with a greater range of shoulder motion and a superior functional outcome, respectively.
肱骨近端肿瘤切除后进行保肢会带来许多挑战。由于除了骨和关节软骨丢失外,盂肱关节的关节周围软组织稳定器也丢失,因此重建的选择有限。本研究旨在评估使用肱骨同种异体-假体复合材料进行保肢后重建的功能结果和存活率。
在一个机构的 16 年期间,连续对 36 例患者进行了同种异体-假体复合材料重建肱骨近端肿瘤切除后的缺陷。30 例在原发性肿瘤切除时进行重建,5 例在先前肿瘤切除重建失败后进行重建,1 例在局部复发切除后进行重建。对有存活患者的平均随访时间为 5 年。测量了重建后的盂肱稳定性、功能、植入物存活率、骨折率和愈合率。根据三角肌切除量、盂肱关节切除是否为关节外或关节内以及切除的肱骨长度分析功能结果和植入物存活率。
1 例患者发生盂肱关节脱位。三角肌切除(部分或完全)导致术后屈伸活动范围减小,但对肌肉骨骼肿瘤学会评分无影响。关节外切除与较低的肌肉骨骼肿瘤学会评分相关。所有患者在最终随访时均有轻度或无疼痛且手功能正常。以翻修为终点,10 年时结构总体估计存活率为 88%。由于假体松动进行翻修导致 3 例失败。4 例患者需要额外的植骨手术来治疗骨愈合部位的延迟愈合。
肱骨近端肿瘤切除后使用同种异体-假体复合材料进行保肢是一种耐用的结构,具有可接受的并发症发生率。三角肌保留和关节内切除分别与更大的肩关节活动范围和更好的功能结果相关。